Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Mini Review

Published on 23 Aug 2022

Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jianquan Yang
Wen Guo
Man Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.895678

3,703 views
8 citations

Review

Published on 22 Aug 2022

Progress in gallbladder cancer with lymph node metastasis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuhang Li
Yinghui Song
Yujing Zhang
Sulai Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.966835

21,380 views
16 citations

Original Research

Published on 19 Aug 2022

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wei-Feng Qu
Meng-Xin Tian
Jing-Tao Qiu
Yu-Cheng Guo
Chen-Yang Tao
Wei-Ren Liu
Zheng Tang
Kun Qian
Zhi-Xun Wang
Xiao-Yu Li

Frontiers in Oncology

doi 10.3389/fonc.2022.968202

6,893 views
21 citations

Brief Research Report

Published on 19 Aug 2022

The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ariel C. Harrison
Fasiha Kanwal
Sumeet K. Asrani
Aaron P. Thrift
Chris I. Amos
Maria L. Jibaja-Weiss
Jane R. Montealegre
Jessica P. Hwang
Amit G. Singal
Hashem B. El-Serag

Frontiers in Oncology

doi 10.3389/fonc.2022.953933

2,748 views
2 citations

Original Research

Published on 19 Aug 2022

Incidence and risk factors of suicide among patients with pancreatic cancer: A population-based analysis from 2000 to 2018

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yifei Ma
Jun Lyu
Bao Yang
Tianao Yan
Qingyong Ma
Zheng Wu
Zheng Wang
Hairong He

Frontiers in Oncology

doi 10.3389/fonc.2022.972908

4,136 views
9 citations

Original Research

Published on 18 Aug 2022

Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Changchang Lu
Yahui Zhu
Weiwei Kong
Ju Yang
Linxi Zhu
Lei Wang
Min Tang
Jun Chen
Qi Li
Jian He

Frontiers in Oncology

doi 10.3389/fonc.2022.879661

5,882 views
4 citations

Original Research

Published on 18 Aug 2022

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xuequan Wang
Ziming Xing
Huazhong Chen
Haihua Yang
Qiupeng Wang
Tongjing Xing

Frontiers in Oncology

doi 10.3389/fonc.2022.953529

4,956 views
10 citations

Original Research

Published on 18 Aug 2022

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wei Huang
Ju Gong
Qingbing Wang
Ziyin Wang
Qin Liu
Jingjing Liu
Junwei Gu
Xiaoyi Ding
Zhiyuan Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.973357

3,621 views
3 citations

Systematic Review

Published on 18 Aug 2022

Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu Zhong
Hong Huo
Shuqi Dai
Su Li

Frontiers in Oncology

doi 10.3389/fonc.2022.964779

3,804 views
10 citations

Original Research

Published on 12 Aug 2022

Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chao Ren
Yifei Ma
Jiabin Jin
Jiachun Ding
Yina Jiang
Yinying Wu
Wei Li
Xue Yang
Liang Han
Qingyong Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.927107

4,010 views
12 citations

Original Research

Published on 12 Aug 2022

The global research status and trends of the application of endoscopic ultrasonography in pancreatic tumors over the last decades: A bibliometric study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chuanchao Xia
Hua Yin
Kecheng Zhang
Zhenhuan Wang
Xiaoli Yang
Haojie Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.980415

2,545 views
1 citation

Systematic Review

Published on 11 Aug 2022

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Matthew Ledenko
Samuel O. Antwi
Shiho Arima
Julia Driscoll
Junji Furuse
Heinz-Josef Klümpen
Finn Ole Larsen
David K. Lau
Annett Maderer
Alice Markussen

Frontiers in Oncology

doi 10.3389/fonc.2022.963753

4,238 views
9 citations

Review

Published on 11 Aug 2022

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Stéphanie Gonvers
Parissa Tabrizian
Emmanuel Melloul
Olivier Dormond
Myron Schwartz
Nicolas Demartines
Ismail Labgaa

Frontiers in Oncology

doi 10.3389/fonc.2022.940473

3,781 views
10 citations

Original Research

Published on 09 Aug 2022

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuxin Liang
Zilong Zhang
Deyuan Zhong
Chunyou Lai
Zonglin Dai
Haibo Zou
Tianhang Feng
Jin Shang
Ying Shi
Xiaolun Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.913731

3,207 views
6 citations

Mini Review

Published on 08 Aug 2022

Proton therapy in the treatment of hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Francesco Dionisi
Daniele Scartoni
Francesco Fracchiolla
Irene Giacomelli
Benedetta Siniscalchi
Lucia Goanta
Marco Cianchetti
Giuseppe Sanguineti
Alberto Brolese

Frontiers in Oncology

doi 10.3389/fonc.2022.959552

6,197 views
2 citations

Original Research

Published on 05 Aug 2022

The clinical impact of endoscopic ultrasound-guided fine-needle aspiration on the patients with low-risk pancreatic cystic lesions

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shubo Pan
Jie Liu
Jiefang Guo
Qilin Zhu
Liangjing Wang
Xiaohua Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.961293

2,394 views
3 citations

Original Research

Published on 03 Aug 2022

High salt intake combined with hypertension elevated the risk of primary liver cancer: a prospective cohort study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tong Liu
Qingsong Zhang
Xiaoli Xiao
Yiming Wang
Xiangming Ma
Mengmeng Song
Qi Zhang
Liying Cao
Hanping Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.916583

3,597 views
11 citations

Original Research

Published on 03 Aug 2022

Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wanmin Liu
Kairong Song
Wei Zheng
Lei Huo
Sisi Zhang
Xiaowen Xu
Peijun Wang
Ningyang Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.862967

2,844 views
6 citations

Original Research

Published on 02 Aug 2022

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Anna Soria
Mariona Calvo
Meritxell Casas
Zara Vidales
Sergio Muñoz-Martínez
Victor Sapena
Marc Puigvehi
Lidia Canillas
Raquel Guardeño
Adolfo Gallego

Frontiers in Oncology

doi 10.3389/fonc.2022.829483

3,132 views
1 citation

Original Research

Published on 02 Aug 2022

Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ran You
Qingyu Xu
Qi Wang
Qingqiao Zhang
Weizhong Zhou
Chi Cao
Xiangzhong Huang
Honghai Ji
Penghua Lv
Hao Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.816198

4,098 views
24 citations

Original Research

Published on 02 Aug 2022

Research trends of artificial intelligence in pancreatic cancer: a bibliometric analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hua Yin
Feixiong Zhang
Xiaoli Yang
Xiangkun Meng
Yu Miao
Muhammad Saad Noor Hussain
Li Yang
Zhaoshen Li

Frontiers in Oncology

doi 10.3389/fonc.2022.973999

8,521 views
26 citations

Original Research

Published on 02 Aug 2022

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ke Su
Lu Guo
Kun He
Mingyue Rao
Jianwen Zhang
Xiaoli Yang
Weihong Huang
Tao Gu
Ke Xu
Yanlin Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.873830

4,962 views
43 citations

Original Research

Published on 01 Aug 2022

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Weiwei Li
Yinxuan Pei
Zixiang Wang
Jinlong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.930868

5,268 views
25 citations

Original Research

Published on 01 Aug 2022

Exosome-transmitted miR-3124-5p promotes cholangiocarcinoma development via targeting GDF11

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huijie Gao
Zhaobin He
Chao Gao
Naiqing Liu
Zhaoyang Zhang
Weibo Niu
Jun Niu
Cheng Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.936507

3,835 views
8 citations

1,079 articles

articles

Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review

Progress in gallbladder cancer with lymph node metastasis

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning

The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy

Incidence and risk factors of suicide among patients with pancreatic cancer: A population-based analysis from 2000 to 2018

Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT

Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis

Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas

The global research status and trends of the application of endoscopic ultrasonography in pancreatic tumors over the last decades: A bibliometric study

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients

Proton therapy in the treatment of hepatocellular carcinoma

The clinical impact of endoscopic ultrasound-guided fine-needle aspiration on the patients with low-risk pancreatic cystic lesions

High salt intake combined with hypertension elevated the risk of primary liver cancer: a prospective cohort study

Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma

Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study

Research trends of artificial intelligence in pancreatic cancer: a bibliometric analysis

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

Exosome-transmitted miR-3124-5p promotes cholangiocarcinoma development via targeting GDF11